ADALAT RET |
CALCHAN MR 10 |
HYPOLAR RET 10 |
NIFE-WOLFF |
UNIPINE XL |
ADALAT IC |
CALCHAN MR 20 |
SLOFEDIPINE XL 30 |
ADIPINE XL |
GENALAT 20 RET |
ADALAT LA 20 |
ANGIOPINE 10 |
NIFEDOTARD 20 MR |
CORODAY MR |
GENALAT 10 RET |
NIMODREL MR 10 |
BAY-A-1040 |
CORACTEN SR |
ANGIOPINE MR 20 |
AFEDITAB CR |
VASAD |
CORACTEN XL |
TENSIPINE MR 10 |
ADALAT |
NIFELEASE |
KENTIPINE MR 20 |
ANGIOPINE 5 |
HYPOLAR XL 30 |
KENTIPINE MR 10 |
ANGIOPINE MR 10 |
ADIPINE MR 20 |
HYPOLAR RET 20 |
NEOZIPINE XL |
NIFEDIPRESS MR 20 |
CALANIF |
FORTIPINE LA40 |
CARDILATE MR |
NIVATEN RET |
ADALAT A.R. |
NIFEDIPINE |
ADALAT LA 60 |
KENTIPINE |
NIFOPRESS MR |
NIMODREL XL |
CALCILAT |
VALNI XL |
TENSIPINE MR 20 |
ADALAT CC |
PROCARDIA |
SLOFEDIPINE XL 60 |
ADANIF XL |
ADALATE LP |
PROCARDIA XL |
NIMODREL MR 20 |
ADIPINE MR 10 |
VALNI 20 RET |
NIFOPRESS RET |
ADALAT LA 30 |
NIFEDIPRESS MR 10 |
NIFENSAR XL |
ANGIOPINE 40 LA |
ADIPINE |
ADALAT® |
NIFEDIPINO |
NIFECOR |
NIFEDIPRES |
4-(2'-NITROPHENYL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDIN-3,5-DICARBONSAEUREDIMETHYLESTER |
NIFECARD |
ADAPINE |
PROCARDIA® |
NIFEDIPINUM |
pubchem.compound:4485 |
drugbank:01115 |
chembl:CHEMBL193 |
chemidplus:21829-25-4 |
rxcui:7417 |
Drug Class | vasodilator agents |
Year of Approval | 1981 |
Drug Class | antianginal agents |
FDA Approval | 1981 |
Drug Class | small molecule |
Drug Indications | Vasodilator Agents |
Drug Indications | Antianginal Agents |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
blocker (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
NIFEDIPINE | Primary Drug Name |
Drug Class | antianginal agents |
Year of Approval | 1981 |
Drug Class | vasodilator agents |
Drug Indications | Antianginal Agents |
Drug Indications | Vasodilator Agents |
Drug Class | small molecule |
C29290 | NCI drug code |
CHEMBL193 | ChEMBL Drug ID |
D04OSE | TTD Drug ID |